http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0068854-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c67d91e3bcde99ada9a8cf726b05b34f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d33bb78ab96eb71a316b2d38b2e2371b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
filingDate 1982-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_229f2e816dd9d86a997350ef22a937ac
publicationDate 1983-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0068854-A1
titleOfInvention A pharmaceutical composition for the treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm
abstract pharmaceutical composition for use in the treatment or prophylaxis of disorders of inflammation and immunity and disorders associated with smooth muscle spasm, comprising dihomo-y-linolenic acid or a bioprecursor thereof in conjunction with a physiologically acceptable lithium salt. Vitamin E and related tocopherols may optionally also be present in the composition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4753964-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0085579-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0289204-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0460848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0146243-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0289204-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2740342-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2574089-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2303302-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0234733-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0457950-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9514490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0085579-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0770391-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0147533-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0391218-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8603518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0391218-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5252333-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0770391-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0147533-A2
priorityDate 1981-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0003407-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129547747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359

Total number of triples: 48.